莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书

智通财经2025-11-14

智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2583224573?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-14 16:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583224573","market":"fut","top_or_hot":-1,"title":"莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1369298.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-14 16:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1369298.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1369298.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1369298.html","article_id":"2583224573","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583224573","pubTimestamp":1763109104,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元人民币。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603168":"莎普爱思","BK0239":"医药制造"},"translate_title":"Shapuaisi (603168. SH) obtained the approval notice for clinical trial of phenylephrine ketorolac solution","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603168":1.5},"content_text":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元人民币。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583224573","isCrawlerRequest":true}